These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 25744546

  • 21. [Lower levels of HDL2 cholesterol are associated with microalbuminuria in patients with type 1 diabetes].
    Bulum T, Duvnjak L, Prkacin I.
    Acta Med Croatica; 2011; 65(3):243-50. PubMed ID: 22359892
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Plasma osteoprotegerin as a biomarker of poor glycaemic control that predicts progression of albuminuria in type 2 diabetes mellitus: A 3-year longitudinal cohort study.
    Moh AMC, Pek SLT, Liu J, Wang J, Subramaniam T, Ang K, Sum CF, Kwan PY, Lee SBM, Tang WE, Lim SC.
    Diabetes Res Clin Pract; 2020 Mar; 161():107992. PubMed ID: 32032675
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Simvastatin reduces plasma osteoprotegerin in type 2 diabetic patients with microalbuminuria.
    Nellemann B, Gormsen LC, Dollerup J, Schmitz O, Mogensen CE, Rasmussen LM, Nielsen S.
    Diabetes Care; 2007 Dec; 30(12):3122-4. PubMed ID: 17804683
    [No Abstract] [Full Text] [Related]

  • 26. Plasma prekallikrein: a risk marker for hypertension and nephropathy in type 1 diabetes.
    Jaffa AA, Durazo-Arvizu R, Zheng D, Lackland DT, Srikanth S, Garvey WT, Schmaier AH, DCCT/EDIC Study Group.
    Diabetes; 2003 May; 52(5):1215-21. PubMed ID: 12716755
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria.
    Yano Y, Kitagawa N, Gabazza EC, Morioka K, Urakawa H, Tanaka T, Katsuki A, Araki-Sasaki R, Hori Y, Nakatani K, Taguchi O, Sumida Y, Adachi Y.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):736-41. PubMed ID: 12574207
    [Abstract] [Full Text] [Related]

  • 31. Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus.
    De Muro P, Fresu P, Formato M, Tonolo G, Mameli M, Maioli M, Sanna GM, Cherchi GM.
    J Nephrol; 2002 Feb; 15(3):290-6. PubMed ID: 12113601
    [Abstract] [Full Text] [Related]

  • 32. High normal albuminuria is independently associated with aortic stiffness in patients with Type 2 diabetes.
    Liu JJ, Tavintharan S, Yeoh LY, Sum CF, Ng XW, Pek SL, Lee SB, Tang WE, Lim SC, SMART2D study.
    Diabet Med; 2014 Oct; 31(10):1199-204. PubMed ID: 24702136
    [Abstract] [Full Text] [Related]

  • 33. Increased plasma serotonin metabolite 5-hydroxyindole acetic acid concentrations are associated with impaired systolic and late diastolic forward flows during cardiac cycle and elevated resistive index at popliteal artery and renal insufficiency in type 2 diabetic patients with microalbuminuria.
    Saito J, Suzuki E, Tajima Y, Takami K, Horikawa Y, Takeda J.
    Endocr J; 2016 Oct; 63(1):69-76. PubMed ID: 26567921
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 37. Urinary adiponectin excretion rises with increasing albuminuria in type 1 diabetes.
    Jorsal A, Petersen EH, Tarnow L, Hess G, Zdunek D, Frystyk J, Flyvbjerg A, Lajer M, Rossing P.
    J Diabetes Complications; 2013 Jun; 27(6):604-8. PubMed ID: 23969018
    [Abstract] [Full Text] [Related]

  • 38. Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes.
    Saraheimo M, Forsblom C, Thorn L, Wadén J, Rosengård-Bärlund M, Heikkilä O, Hietala K, Gordin D, Frystyk J, Flyvbjerg A, Groop PH, FinnDiane Study Group.
    Diabetes Care; 2008 Jun; 31(6):1165-9. PubMed ID: 18346990
    [Abstract] [Full Text] [Related]

  • 39. Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
    Jorsal A, Tarnow L, Flyvbjerg A, Parving HH, Rossing P, Rasmussen LM.
    Diabetologia; 2008 Nov; 51(11):2100-7. PubMed ID: 18719882
    [Abstract] [Full Text] [Related]

  • 40. Hemorheology, plasma protein composition and von Willebrand factor in type I diabetic nephropathy.
    Zimmermann J, Schramm L, Wanner C, Mulzer E, Henrich HA, Langer R, Heidbreder E.
    Clin Nephrol; 1996 Oct; 46(4):230-6. PubMed ID: 8905207
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.